Selection of blockbuster announcements

1、$TENCENT (00700.HK)$9.853 million shares were issued under the share incentive scheme and about 5.5169 million share options were granted on the same day

Tencent announced that on August 18, the board of directors had decided to issue a total of 9.853 million new shares in accordance with the general authority granted by the company's shareholders at the 2022 annual general meeting, including a total of 9.683 million award shares to no less than 6300 award holders under the share incentive Scheme for the period from November 2021 to March 2022. In addition, Tencent announced that a total of 5516928 share options were granted under the 2017 share option scheme on August 18 at an exercise price of HK $312.6 per share, valid until the last day of the seven-year period after the date of the share option grant.

2、$NetEase, Inc.-S (09999.HK)$Release of second quarter results: net profit of 5.291 billion yuan, an increase of 49.4% over the same period last year.

NetEase, Inc-S released its main financial results for the second quarter of 2022, with net income of 23.2 billion yuan (RMB, the same below), an increase of 12.8% over the same period last year, gross profit of 12.9 billion yuan, an increase of 15.7% over the same period last year, and continuing operating net profit of 4.7 billion yuan belonging to shareholders of the company. Net profit belonging to shareholders of the company was 5.291 billion yuan, an increase of 49.4% over the same period last year, and basic continuing operating net profit per share was $0.21. The second quarter dividend was $0.0720 per share ($0.3600 per American depositary share). Of this total, the net income from games and related value-added services was 18.1 billion yuan, up 15.0% from the same period last year; Youdao, Inc's net income was 956.2 million yuan; the net income from cloud music was 2.2 billion yuan, up 29.5% from the same period last year; and the net income from innovation and other businesses was 1.9 billion yuan, up 6.1% from the same period last year.

3、$Ganfeng Lithium (01772.HK)$Signed a strategic cooperation agreement with GAC

Ganfeng Lithium announcement, and$GAC GROUP (02238.HK)$Guangqi Ean New Energy vehicle Co., Ltd. recently signed a "Strategic Cooperation Agreement". The two sides agreed to establish a long-term strategic cooperation relationship and cooperate from the upstream material end of new energy power battery. continue to explore in-depth cooperation in lithium resources development, mid-stream lithium salt deep processing and comprehensive recycling of waste batteries, so as to bring sustainable value to both sides and achieve win-win results. Ganfeng Lithium gives full play to his advantages in battery core raw materials such as lithium carbonate to provide GAC Ean or its (potential) suppliers with both reliable and cost-effective raw materials to help GAC Ean's new energy vehicle project. enhance the scientific and technological added value and competitiveness of the GAC Ean brand. Ganfeng Lithium also decided to participate in the project in which GAC Ean introduced strategic investors through capital increase and share expansion.

4、$KINGDEE INT'L (00268.HK)$The loss in the first half of the year widened by 43.7% to 356 million yuan without interim interest.

Kingdee International Software Group announced that revenue rose 17.3% year-on-year to 2.197 billion yuan (RMB, the same below) in the first half of June, but the loss attributable to shareholders widened to 356 million yuan, with a loss of 0.1038 yuan per share without interim interest.

5、$China Literature (00772.HK)$拟To carry out a share buyback plan with a maximum total capital of 700 million yuan

China Literature issued an announcement that the company's board of directors approved the proposed share repurchase plan and intended to exercise the power under the general authority (repurchase authority) granted by the company's shareholders to the board of directors at the annual general meeting held on May 23, 2022, in order to repurchase the company's shares, shareholders approve a repurchase authority in the market that accounts for no more than 10% of the company's issued shares on the date of the annual general meeting. Any shares repurchased after the expiry of the existing Repurchase mandate shall not be confirmed until the general authority has been granted by the shareholders to the Board of Directors in respect of the repurchase shares at the next annual general meeting of the Company in 2023. It is reported that according to the repurchase authorization, the maximum number of shares that can be repurchased is about 102 million shares, and the maximum amount of funds to be used is RMB700 million.

6、$CTG DUTY-FREE (01880.HK)$The Hong Kong IPO is priced at HK $158 and listed on August 25.

China waiver announcement, the offering price has been set at HK $158.00 per H share. Trading of H shares is expected to commence on the main board of the Hong Kong Stock Exchange at 09:00 on Thursday, August 25, 2022. The H shares will be traded at the stock code 1880 per share.

7、$BIOCYTOGEN-B (02315.HK)$Proposed issue of 21.7585 million H sharesThe IPO will begin on August 19th.

The company plans to sell 21.7585 million H shares globally, with a Hong Kong public offering accounting for 10 per cent, an international offering accounting for 90 per cent, and an over-allotment of 15 per cent. Trading in H shares is expected to commence on the Hong Kong Stock Exchange at 09:00 (Hong Kong time) on Thursday, September 1, 2022.

Listing of new shares

Shuangcaizhuang (02321) goes public today

China waiver (01880): the offering price is set at HK $158per H share.

Bai Oseto-B (02315) plans to issue 21.7585 million shares to introduce cornerstone investors such as Rongchang Biological and Sanjin International.

Important matters

Sun City Group (01383) changed its name to "LET Group Holdings Limited"

Shunfeng City (09699): application for full circulation of H shares approved by China Securities Regulatory Commission

Financial data

The revenue of Cloud Music (09899) in the first half of the year increased by 33.8% compared with the same period last year, the gross profit margin improved significantly, and the online music payment rate soared to 20.7%.

Ping An Healthcare And Technology (01833) released interim results with an income of 2.828 billion yuan.

Shu Lang (02385) released interim results with an adjusted net profit of 17.516 million yuan.

Lee Hing Development (00068) medium-term profit attributable to shareholders of HK $126 million

The medium-term net profit of Jiutai Bangda Energy (02798) was 401 million yuan, an increase of about 369.1% over the same period last year.

Medium-term income of Dali International (00608) rose 49.3% to HK $1.806 billion

Strength Development (01277) medium-term net profit is about 1.365 billion yuan, an increase of 48.0% over the same period last year.

The core net profit of Yuexiu Real Estate (00123) in the first half of the year reached 2.13 billion yuan, and the "three red lines" kept the "green file" up to standard.

SOHO China (00410) the net profit attributable to equity shareholders in the first half of the year is about 200 million yuan.

The medium-term net profit of China Merchants Land (00978) was 250 million yuan, a decrease of about 16% compared with the same period last year.

Bank of China Aviation Leasing (02588) has a first-half net after-tax loss of $313 million and interim interest of $0.0889.

The medium-term net profit of Minmetals Resources (01208) was 79.5 million US dollars, down 80% from the same period last year.

Parkson Group (03368) turned profit and loss to 197.5 million yuan in the first half of the year.

The medium-term net profit of Golden Eagle Trading Group (03308) was 461 million yuan, a decrease of 48.1% over the same period last year.

Kingdee International Software Group (00268) made a net loss of about 356 million yuan in the first half of the year.

The medium-term loss of CDI (01062) widened to about HK $353.13 million.

Maoye International (00848) had a medium-term net profit of 100 million yuan, an increase of 34.5% over the same period last year.

Medium-term income of Zaitong (00062) was HK $2.947 billion, down 13.56% from the same period last year.

Performance forecast

Lion Rock Group (01127) Yingxi: expected medium-term net profit of HK $140 million

Huafa property Services (00982) Yingxi: expected medium-term net profit growth of more than 40%

China Management Industry (00380) Yingxi: expected medium-term net profit to increase by 35% MUE 45%

Century City International (00355) Yingxi: expected medium-term net profit of about HK $137 million

Bailibao Holdings (00617) Yingxi: expected to turn from a loss to a profit of about HK $230 million in the medium term

MATRIX HOLDINGS (01005) Yingxi: expected medium-term net profit to increase by 80% to 110%

Regal Hotel (00078) Yingxi: it is expected to turn from a loss to a profit of about HK $138 million in the medium term.

Datang West City (00620) Yingxi: the first half profit is expected to be about HK $121 million-131 million.

Lianyirong Technology-W (09959) expects to make an adjusted profit of about 125 million-130 million yuan in the first half of the year.

Shanghai Zendai (00755) earnings warning: it is expected that the loss attributable to the company's owners will increase in the first half of the year compared with the same period last year.

Jiangshan Holdings (00295) expects a medium-term loss of about 70 million to 100 million yuan.

Rex International (02222) earnings warning: expected medium-term profit to fall by more than 95%

Sihai International (00120) Yingxi: expected medium-term net profit of about HK $87 million

Think Music Education (01769) earnings warning: expected net loss in the first half of the year is about 30 million-35 million yuan

China Science Biology (01237) PCCW: it is expected that the net profit in the first half of the year will decrease by about 50% compared with the same period last year.

Merger and acquisition and sale

Bay area Development (00737) plans to inject 2.998 billion yuan into the company along the Yangtze River to acquire its enlarged 51% stake.

Ruici Medical (01526) intends to sell its shares in Ruici Narcissus and Ruizi Ruijing for no more than 299 million yuan.

Ruici Medical (01526) intends to subscribe for Unicorn II Holdings shares with 180 million yuan.

Lifeng (Group) (00387) intends to sell its Prima shares for HK $132 million and declare a special interest of HK $0.080.

Investment and operation

Ganfeng Lithium (01772): signed a strategic cooperation agreement with GAC

Ruike Bio-B (02179): a comparative study of ReCOV and mRNA vaccines has been completed. All subjects have been enrolled and vaccinated.

CSPC Pharmaceutical (01093): Donda (mitoquinone hydrochloride liposome injection) was approved in clinical trial for the treatment of optic neuromyelitis pedigree disease.

San Nuo Pharmaceuticals-B (02257): core product RNAi therapeutic drug STP705 phase I/II clinical trial for the treatment of facial in situ squamous cell skin cancer completes the first case of subject administration

Kandelai Medical equipment (01501) plans to set up Chengdu Waige Fund to invest in early or growing enterprises in the medical and biotechnology industries.

Cat's Eye Entertainment (01896) and Shanghai Yueting enter into a framework agreement on entertainment content investment and production cooperation.

Beijing controlled Urban Resources (03718) won the bid for the project of urban and rural sanitation integration and greening in Ningjin, Dezhou, Shandong Province.

Pudat Technology (00650): Shanghai Ruinai sells 9 sets of solar cell cashmere equipment

Repurchase cancellation

Standard Chartered PLC (02888) spent 7.735 million pounds to buy back 1.295 million shares on August 17.

ASMPT (00522) spent HK $5.325 million to buy back 82400 shares on Aug. 18.

China Literature (00772) suggested a share buyback plan with a maximum total fund of 700 million yuan.

Equity incentive

Tencent (00700) granted a total of 5.517 million share options

Tencent (00700) issued a total of 9.853 million award shares

China Literature (00772) granted a total of 5.3092 million share options

China Literature (00772): issue 1.8788 million new shares according to the plan of the restricted share unit

Melco International Development (00200): Melco Resorts and Entertainment Ltd agrees to repurchase 9.996 million common shares and 25 million restricted American depositary shares from Melco,Leisure

Wuxi Biologics (02269) granted a total of 1.744 million restricted shares to 151employees

Wuxi Biologics (02269): WuXi XDC granted a total of 9.053 million share options to 66 WuXi XDC employees

Debt financing

China ship Leasing (03877) received $300m in term loan financing and $400m in revolving loan financing.